Abstract:Background Cellular repressor of E1A-stimulated genes (CREG) is an important endothelial-protective gene, which is reported to modulate the mobility of endothelial cells. Objective The study aimed to investigate the effects of CREG on endothelial angiogenesis. Methods Aortic expression of CREG protein was detected by western blot and immnuostaining in CREG heterozygous (CREG+/-) mice and wild-type littermates. Perfusion recovery of hind limb was valued by laser Doppler in mice and wild-type littermates 14 days after the hind limb arterial ligation. The matrigel experiments in vivo and in vitro were performed after the human umbilical vein endothelial cells (HUVEC) were infected by adenovirus overexpressing CREG or adenovirus expressing GFP as control, and the filopodium formation was observed to evaluate the CREG function on neovascularization. Different integrin-linked kinase (ILK) subunit site mutant plasmids and small interfering RNA identified p-Cdc42 were transfected into HUVEC to explore the mechanism through which CREG-mediated endothelial angiogenesis. Results Aortic expression of CREG protein was detected to reduce remarkably in CREG+/- mice compared to that in wild-type littermates. Meanwhile, laser Doppler perfusion imaging showed that perfusion recovery was significantly impaired in CREG+/- mice than that in wild-type littermates after 14 days hind limb arterial ligation (78.23 ± 7.2% vs 12.15 ± 2.058% in calf; 58.23 ± 6.5% vs 32.15 ± 3. 514% in thigh; P < 0.001). Subsequently, overexpression of CREG in HUVEC increased endothelial cell network formation in vitro, enhanced neovascularization and improved limb perfusion in vivo, accompanied by filopodium formation and changes in cell shape. Mechanismly, integrin-linked kinase (ILK), a key adhesion plaque protein, participated in CREG-mediated endothelial angiogenesis. Furthermore, studies using small interfering RNA identified p-Cdc42 to be a key downstream molecule of ILK involved in CREG-mediated endothelial cell filopodium formation. Transfection with binding-site-mutant plasmids of ILK and co-immunoprecipitation revealed that CREG activated the ILK-PINCH complex, which is involved in the regulation of p-Cdc42 activation. Conclusions CREG overexpression stimulates the endothelial filopodium formation and regulates angiogenesis via the ILK/PINCH/p-Cdc42 signalling pathway, which provides the basis for future studies in the field of angiogenesis.

Cellular Repressor E1A-stimulated Genes Controls Phenotypic Switching of Adventitial Fibroblasts by Blocking P38mapk Activation.

ASSA13-10-13 Cellular Repressor E1A-Stimulated Genes Controls Phenotypic Switching of Adventitial Fibroblasts by Blocking P38mapk Activation

The change of cellular repressor of E1A-stimulated genes during adventitial fibroblast phenotypic switching

CREG mediated adventitial fibroblast phenotype modulation: a possible therapeutic target for proliferative vascular disease.

Cellular Repressor of E1A-Stimulated Genes is a Critical Determinant of Vascular Remodeling in Response to Angiotensin II

AGEs Increased Migration and Inflammatory Responses of Adventitial Fibroblasts Via RAGE, MAPK and NF-κB Pathways

Cellular Repressor of E1A-stimulated Genes Inhibits Human Vascular Smooth Muscle Cell Apoptosis Via Blocking P38/JNK MAP Kinase Activation.

ASSA13-10-14 Cellular Repressor of E1A-Stimulated Genes Accelerates Endothelial Angiogenesis Via Integrin-Linked Kinase-PINCH-CDC42 Activation

CREG inhibits migration of human vascular smooth muscle cells by mediating IGF-II endocytosis.

CREG Ameliorates the Phenotypic Switching of Cardiac Fibroblasts after Myocardial Infarction Via Modulation of CDC42

Cellular Repressor of E1A-stimulated Genes, A New Potential Therapeutic Target for Atherosclerosis.

Overexpression of CREG Attenuates Atherosclerotic Endothelium Apoptosis Via VEGF/PI3K/AKT Pathway.

[Over-Expression of the Cellular Repressor of E1A-stimulated Genes Inhibits the Apoptosis of Human Vascular Smooth Muscle Cells in Vitro.].

CREG: a possible candidate for both prevention and treatment of proliferative vascular disease.

The Change of Cellular Repressor of E1A-stimulated Genes During Carotid Vascular Remodeling

Cellular repressor of E1A stimulated genes enhances endothelial monolayer integrity

CREG Promotes a Mature Smooth Muscle Cell Phenotype and Reduces Neointimal Formation in Balloon-Injured Rat Carotid Artery

Cellular Repressor of E1A-stimulated Genes Inhibits the Migration of Human Vascular Smooth Muscle Cells via Binding of the M6P/IGF2R(11-13) Domains

Expression of Cellular Repressor of E1A-stimulated Genes in Atherosclerotic Artery

Overexpression of cellular repressor of E1A-stimulated genes inhibits migration of vascular smooth muscle cells

Cellular Repressor of E1a-Stimulated Genes Inhibits Inflammation to Decrease Atherosclerosis in Apoe(-/-) Mice